Overall rank by patents
#38,304
Across all tracked assignees
USPTO PatentsView assignee record - 7 granted patents across 1 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61B (DIAGNOSIS; SURGERY; IDENTIFICATION).
The verdict
Wesper holds 7 US patents across 1 technology areas, rank #38,304 of 50,000 tracked assignees.
Wesper Inc. has been granted 7 US utility patents between 2022 and 2025, placing Wesper Inc. at rank #38,304 across all assignees tracked by PlainPatent. This portfolio spans 1 distinct Cooperative Patent Classification (CPC) subclasses, averaging 8.0 claims per patent with primary concentration in A61B (DIAGNOSIS; SURGERY; IDENTIFICATION). As a US Corporation, Wesper Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Wesper sits between Wellsim Biomedical Technologies, Inc. (7 patents, rank #38,300) and Whisker Labs, Inc. (7 patents, rank #38,308) - the closest US assignees by grant volume. The composite Innovation Score of 35.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 7 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Wesper Inc.'s 8.0 average claims per patent suggests focused, narrowly drawn claims typical of single-invention filings, while specialization in 1 subclass reflects a tightly scoped invention area. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Wesper Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
WellSIM Biomedical Technologies, Inc.
7 patents
Wellmark International
7 patents
Wells Lamont Industry Group LLC
7 patents
Wenger Corporation
7 patents
WestRock Dispensing Systems, Inc.
7 patents
Westendorf Manufacturing Co., Inc.
7 patents
WheelRight Limited
7 patents
Whisker Labs, Inc.
7 patents
Wesper Inc.
7 patents
What this shows Wesper holds 7 patents at rank #38,304, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #38,304 in granted patent volume.
Other assignees with the most granted patents in Wesper's primary technology class.
Wesper's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
36 Top 49% higher than 51% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 2 | 28.6% |
| 2023 | 2 | 28.6% |
| 2024 | 2 | 28.6% |
| 2025 | 1 | 14.3% |
Top 1 of 1 technology areas
Overall rank by patents
#38,304
Across all tracked assignees
35.5 out of 100
How to use this portfolio
Wesper's 7 grants land it in the top 49% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.